Back to search

University of Alabama Birmingham

Appropriately timed epigenetic manipulation with histone deacetylase inhibitors as a platform approach to tumor immunotherapy

Abstract

dc:description.abstract

In contrast to chemotherapy and radiotherapy, immunotherapy is able to respond in proportion to tumor burden and continue to evolve in parallel with the tumor mass and metastatic sites. In this way, immune-based cancer therapies are a living drug and hold enormous potential. In this work, we enforce expression of MHCII on a murine breast cancer model to study how changes in tumor biology can drive improved T cell-mediated responses. We next use histone deacetylase inhibitors to manipulate the microenvironment through a more clinically relevant, therapeutic approach. Herein, improvements in tumor control were driven by CD8 T cells and IFNγ, suggesting the in vivo mechanism of these drugs to be distinct from that of impaired tumor cell growth in vitro. In an attempt to reconcile reportedly paradoxical effects of HDAC inhibition, we then propose and demonstrate that the ultimate impact of these agents is wholly dependent on the timing in which treatment is initiated relative to T cell activation status. If appropriately timed, HDAC inhibition can stimulate robust anti-tumor immunity. In this way, we identify timing as a new paradigm and paramount consideration in combinatorial strategies incorporating HDAC inhibitors for the treatment of solid tumors.

Degree

thesis:*
Level thesis:degree_level
Dissertation

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McCaw, Tyler
Contributors dc:contributor
  • Troy Randall
  • Troy D Randall
  • Antonio Di Stasi
  • Robin G Lorenz
  • Tim M Townes
  • Casey T Weaver

Subjects

dc:subject × 7

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

McCaw, Tyler. Appropriately timed epigenetic manipulation with histone deacetylase inhibitors as a platform approach to tumor immunotherapy. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/2418